icometrix Information

Transforming patient care through imaging AI Founded in 2011, icometrix (Leuven, Belgium; Boston, USA), now a GE HealthCare company, strives to bring data-driven insights into clinical practice, supporting more informed and personalized patient care. icometrix develops clinically validated AI solutions that translate brain MRI and CT scans into structured, quantitative outputs for radiological reporting and the clinical management of neurological disorders, including multiple sclerosis, traumatic brain injury, epilepsy, stroke, dementia, and Alzheimer’s disease. icobrain integrates into the reporting workflow, encoding how neurological imaging findings are consistently assessed and communicated. icompanion, a digital platform and mobile app, enables people with MS and their care teams to monitor symptoms and treatment in a structured, longitudinal way. Today, icometrix is internationally active and integrated into several hundred clinical practices. The company collaborates with healthcare providers and pharmaceutical organizations to support clinical research and the evaluation of therapies in neurological disorders.